Randomized, double blind, placebo-controlled trial of a TNF inhibitor (ETANERCEPT) for the treatment of idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) study Meeting Abstract
| Authors: | Yanik, G.; Ho, V. T.; Horowitz, M.; Weisdorf, D. J.; Logan, B. R.; Wu, J.; Soiffer, R. J.; Wingard, J. R.; Levine, J. E.; Ferrara, J. L. M.; Giralt, S. A.; White, E.; Carter, S. L.; DiFronzo, N.; Cooke, K. R. |
| Abstract Title: | Randomized, double blind, placebo-controlled trial of a TNF inhibitor (ETANERCEPT) for the treatment of idiopathic pneumonia syndrome (IPS) after allogeneic stem cell transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) study |
| Meeting Title: | 2013 BMT Tandem Meetings |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 19 |
| Issue: | 2 Suppl. 2 |
| Meeting Dates: | 2013 Feb 13-17 |
| Meeting Location: | Salt Lake City, UT |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-02-01 |
| Start Page: | S169 |
| Language: | English |
| ACCESSION: | WOS:000314441900109 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.bbmt.2012.11.141 |
| Notes: | - Oral Presentations Meeting Abstract: 108 - BMT Tandem Meetings - FEB 13-17, 2013 - Salt Lake City, UT - "2" - "Source: Wos" |
